C07H 19/23
Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or
Official title: Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
C07H19/23 (Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or) appears on 190 US grants and 266 published applications in this corpus.
Search patents in C07H- Granted patents
- 190
- Published applications
- 266
- Assignees
- 143
- Inventors
- 620
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 8 |
| 2003 | 6 | 11 |
| 2004 | 6 | 16 |
| 2005 | 5 | 6 |
| 2006 | 7 | 11 |
| 2007 | 4 | 5 |
| 2008 | 2 | 5 |
| 2009 | 7 | 13 |
| 2010 | 10 | 12 |
| 2011 | 6 | 14 |
| 2012 | 8 | 4 |
| 2013 | 9 | 12 |
| 2014 | 11 | 9 |
| 2015 | 5 | 6 |
| 2016 | 7 | 13 |
| 2017 | 5 | 11 |
| 2018 | 6 | 9 |
| 2019 | 7 | 15 |
| 2020 | 9 | 11 |
| 2021 | 15 | 22 |
| 2022 | 13 | 15 |
| 2023 | 11 | 6 |
| 2024 | 7 | 14 |
| 2025 | 6 | 9 |
| 2026 | 4 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Adenosine analog and its use in regulating the circadian clock30 Jun 2026US 12,667,584 B2National Institute of Biological Sciences, Beijing
- Bioluminescent detection of DNA synthesis21 Apr 2026US 12,606,863 B2Promega Corporation
- Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates24 Mar 2026US 12,583,882 B2Mireca Medicines GmbH
- CD73 inhibitors17 Mar 2026US 12,577,272 B2Oric Pharmaceuticals, Inc.
- Modulators of 5′-nucleotidase, ecto and the use thereof4 Nov 2025US 12,459,967 B2Arcus Biosciences, Inc.
- Substituted bicyclic heterocycle compounds, compositions, and uses thereof1 Oct 2026US 2026/0294949 A1
- Adenosine analog and its use in regulating the circadian clock1 Oct 2026US 2026/0294952 A1National Institute of Biological Sciences, Beijing
- Modulators of 5'-nucleotidase, ecto and the use thereof28 May 2026US 2026/0146059 A1Arcus Biosciences, Inc.
- Cd73 inhibitors12 Feb 2026US 2026/0042794 A1Oric Pharmaceuticals, Inc.
- Nucleoside line-1 inhibitors5 Feb 2026US 2026/0035403 A1Transposon Therapeutics, Inc.
Most cited
By later US patents
- Methods and compositions for treating flaviviruses and pestiviruses187US 7,105,493 B2Idenix Pharmaceuticals, Inc. · 2006
- Covalently linked oligonucleotide minor grove binder conjugates158US 5,801,155 AEpoch Pharmaceuticals, Inc. · 1998
- Methods and compositions for treating flaviviruses and pestiviruses152US 6,812,219 B2Idenix Pharmaceuticals, Inc. · 2004
- Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders133US 6,312,894 B1Epoch Pharmaceuticals, Inc. · 2001
- Methods and compositions for treating flaviviruses and pestiviruses131US 7,148,206 B2Idenix Pharmaceuticals, Inc. · 2006